Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

Medi Caps Ltd (MEDICAPQ) Share Price & Fundamentals

SegmentOfferingsAdvantages / MoatCustomersHigh-Margin AreasRevenue (₹ Cr.)Revenue %How We EarnPricing ModelGrowth DriversTop Brands
Pharma DivisionManufacture and supply of empty hard gelatin capsules for pharmaceutical firms.Second-largest manufacturer in India; strong client relationships; ISO certification.Pharmaceutical companies such as Dr. Reddy's and Lupin Laboratories.Capsule manufacturing had high margins prior to discontinuation.2390Sales of capsules to pharma companies (B2B).Direct sales, volume-based pricing.Legacy pharma demand, though manufacturing ceased in 2019, still residual operations.
Real Estate DivisionDevelopment and leasing of commercial real estate – specifically Medi Caps Business Park.Exclusive land assets; transition strategy leveraging real estate sector growth.Businesses leasing commercial space; real estate buyers in Indore region.High-margin leasing and property sales potential.210Rental income and project sales in real estate sector.Project-based sales and long-term leases.Urban development demand and asset monetization in Indore.

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions